'The patient': at the center of patient-reported outcomes

被引:13
作者
Awad, A. George [1 ,2 ]
机构
[1] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[2] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
关键词
decision-making; patient-reported outcomes; patients; self-reported; QUALITY-OF-LIFE; ATYPICAL ANTIPSYCHOTICS; SCHIZOPHRENIA; IMPACT;
D O I
10.1586/14737167.2015.1077118
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The recent emphasis of including patient reports in their own care management is reviewed in terms of the factors that contributed to its popularity. The role change of patients as being active participants in their own care as a result of the rising consumerism and advocacy has led to increased pressures for including patients in the therapeutic decision-making process. As consumers of clinical services, their perspectives and attitudes towards health and illness acquired more importance. The rising cost of healthcare has added another dimension in cost containment by empowering patients and sharing responsibility in their recovery, which hopefully can improve outcomes. Challenges in the development and implementation of patient-reported outcomes in psychiatry are reviewed and include the still unresolved subjective/objective dichotomy, identification of the most appropriate and relevant patient-reported outcomes. Few outcomes are identified and include: subjective tolerability of medication, self-reported health-related quality of life, preferences, patients' attitudes towards health and illness, satisfaction with medication and overall satisfaction of quality of care, and functional state, with particular focus on social functioning.
引用
收藏
页码:729 / 731
页数:3
相关论文
共 17 条
[1]  
[Anonymous], ISPOR GOOD PRACT OUT
[2]  
[Anonymous], PATIENTS EYES
[3]  
[Anonymous], MANAGEMENT ISSUES SC
[4]  
[Anonymous], PAT CTR CAR IM UNPUB
[5]  
[Anonymous], ZUNKUNFTS PERSPECTIV
[6]   The Impact of Newer Atypical Antipsychotics on Patient-Reported Outcomes in Schizophrenia [J].
Awad, A. George ;
Voruganti, Lakshmi N. P. .
CNS DRUGS, 2013, 27 (08) :625-636
[7]   Measuring Quality of Life in Patients with Schizophrenia An Update [J].
Awad, A. George ;
Voruganti, Lakshmi N. P. .
PHARMACOECONOMICS, 2012, 30 (03) :183-195
[8]  
Awad AG, 2010, EXPERT REV PHARM OUT, V10, P1, DOI [10.1586/erp.10.2, 10.1586/ERP.10.2]
[9]   Impact of atypical antipsychotics on quality of life in patients with schizophrenia [J].
Awad, AG ;
Voruganti, LNP .
CNS DRUGS, 2004, 18 (13) :877-893
[10]   The importance of measuring psychosocial functioning in schizophrenia [J].
Brissos, Sofia ;
Molodynski, Andrew ;
Dias, Vasco Videira ;
Figueira, Maria Lusa .
ANNALS OF GENERAL PSYCHIATRY, 2011, 10